Bayer

BAYN.DEApproved

Founded 2023bayer.com

Bayer AG is one of the world's largest pharmaceutical and life sciences companies, headquartered in Leverkusen, Germany. The company develops and commercializes innovative therapies across oncology, cardiology, ophthalmology, and hematology, while also maintaining leading positions in consumer health products and agricultural sciences. With operations in over 100 countries and approximately 100,000 employees globally, Bayer continues to focus on breakthrough innovations in health and nutrition.

Market Cap

$43.5B

Founded

2023

Employees

95,000-105,000

Focus

BiologicsSmall Molecules

BAYN.DE · Stock Price

USD 38.3826.69 (-41.01%)

Historical price data

AI Company Overview

Technology Platform

Bayer operates multiple platforms including targeted oncology therapies, cardiovascular treatments, ophthalmology solutions, and agricultural biotechnology, with increasing focus on precision medicine and digital health solutions.

Pipeline Snapshot

1000

1000 drugs in pipeline, 360 in Phase 3

Drug	Indication	Stage
Darolutamide 300 mg + Androgen deprivation therapy	Prostatic Cancer, Castration-Resistant	Phase 3
Copanlisib (Aliqopa, BAY80-6946) + Placebo + Rituximab	Lymphoma,Non-Hodgkin	Phase 3
Polyethylene Glycol 3350 Powder for Solution (PEG 3350) + Polyethylene Glycol 40...	Constipation	Phase 3
Methylprednisolone and IVIG + Placebo and IVIG	Immune Thrombocytopenic Purpura	Phase 3
Naproxen Sodium ER (BAYH6689) + Naproxen Sodium IR (Aleve, BAYH6689) + Naproxen ...	Pain, Postoperative	Phase 3

FDA Approved Drugs

HYRNUONDANov 19, 2025

LYNKUETNDAOct 24, 2025

NAPROXEN SODIUMANDAJan 10, 2023

Opportunities

Bayer has significant growth opportunities through its robust pharmaceutical pipeline, expansion in emerging markets, and development of sustainable agricultural solutions.

The company's focus on precision medicine and digital health technologies positions it well for future healthcare trends.

Risk Factors

Key risks include ongoing litigation related to Roundup, patent cliff challenges for major pharmaceutical products, and high debt levels from the Monsanto acquisition.

Regulatory pressures and intense competition across all business segments also present ongoing challenges.

Competitive Landscape

Bayer competes with pharmaceutical giants like Roche, Novartis, and Pfizer in therapeutics, while facing competition from Corteva and Syngenta in agriculture. The company differentiates itself through its integrated life sciences approach and strong presence across multiple therapeutic areas and geographic markets.

Publications

Patents

Pipeline

1000

FDA Approvals